| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4029887 | Ophthalmology | 2006 | 8 Pages |
Abstract
Transplantation of AS-derived cultivated corneal epithelial equivalents was shown to be a feasible method of treating patients with severe ocular surface disease. The use of AS is of clinical importance in the development of autologous xenobiotic-free bioengineered ocular surface equivalents for clinical transplantation.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Takahiro MD, PhD, Tsutomu MD, PhD, Chie MD, PhD, Leonard P.âK. MD, Noriko MD, PhD, Norihiko MD, PhD, Shigeru MD, PhD,